Thomas W. Dubensky, Chief Scientific Officer at ADURO BIOTECH, INC. (ADRO), sold 144,301 shares at $10.10 ($1.4M) on 2017-06-02, disclosed to the SEC on 2017-06-05.
Scheduled sale ($1.4M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.00 | 77,971 | $780K | 53.9% |
| 2 | $10.10 | 48,753 | $492K | 34.0% |
| 3 | $9.99 | 17,577 | $176K | 12.1% |
| Total | $10.03 avg | 144,301 | $1.4M | 100% |
| Filing → |
| ADRO | SELL | 2017-07-06 | $567K | — | Filing → |
| ADRO | SELL | 2017-05-15 | $57K | — | Filing → |
| ADRO | SELL | 2017-03-10 | $274K | — | Filing → |